S&D Co., Ltd (KOSDAQ: 260970)

Market Cap	132.78B
Revenue (ttm)	106.44B
Net Income (ttm)	15.72B
Shares Out	2.89M
EPS (ttm)	4,449.73
PE Ratio	10.32
Forward PE	7.03
Dividend	n/a
Ex-Dividend Date	Dec 27, 2024

Volume	38,879
Average Volume	72,394
Open	47,000
Previous Close	46,550
Day's Range	45,500 - 47,500
52-Week Range	16,040 - 60,300
Beta	0.98
RSI	56.07
Earnings Date	Mar 14, 2025

About S&D Co., Ltd

S&D Co., Ltd develops and sells health functional food in South Korea. The company offers general functional food ingredients, health-oriented functional ingredients, and biological industry materials for the sleeping problems and glycoconjugate gastric functions. It provides health-oriented functional ingredients, such as Lindera glauca extract, Rice bran Extract, MPG-6/MPGT, RCS, and Xanthorrhizol, as well as other materials, including Pagopyridol, SD 1002F, and Panduratin. The company also offers general functional food ingredients comprisin...

• Industry: Miscellaneous Food Preparations And Kindred Products
• Founded: 1998
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 260970

Financial Performance

In 2023, S&D Co., Ltd's revenue was 88.28 billion, an increase of 20.40% compared to the previous year's 73.32 billion. Earnings were 11.87 billion, an increase of 20.58%.